real world use of car t-cell therapy in multiple myeloma
Published 2 years ago • 280 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
4:14
challenges with the real-world use of car-t therapy in multiple myeloma
-
0:45
car t-cell therapy in lenalidomide-refractory multiple myeloma
-
1:38
challenges of car-t therapy in the real-world setting
-
1:02
the use of car-t cell products in a real-world setting
-
2:40
car t-cell therapy to revolutionize multiple myeloma?
-
3:27
car-t cells in myeloma
-
1:21
developing off-the-shelf car t-cells to treat multiple myeloma
-
2:35
latest advances in car-t for multiple myeloma: cilta-cel & new car-t platforms
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:12
car t-cell therapy economics in the real world
-
4:15
car-t cells: current climate and future perspectives in multiple myeloma
-
1:39
the role of myeloid cells in car-t cell therapy
-
1:39
paradigm-changing car t-cell therapy for multiple myeloma
-
2:45
car-t treatment outcomes: mm real-world data
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
3:03
the value of real-world data in the car-t field
-
2:05
the cost-effectiveness of car t-cell therapy
-
2:37
car-t cells for myeloma: experience from china